Novel Class of Drugs May Inhibit Antibiotic Resistance in Bacteria
November 25th 2016On their quest to put an end to a threat that may change modern medicine as we know it, researchers discovered four chemicals that disrupt AcrA, an efflux pump protein, that contributes to antibiotic resistance in bacteria.
Examining the Business of Infectious Diseases in the Time of Zika Virus
November 23rd 2016Most biotech and pharmaceutical companies focus their research efforts on cures for chronic diseases that plague the majority of the population because that’s where the money lies; however, is the rise in devastating infectious diseases such as Zika redirecting the lens of many companies?
Madison County Experiences Staggering 90% Increase in Syphilis Cases
November 22nd 2016The Alabama Department of Public Health has issued a health advisory in an attempt to increase awareness and prevention efforts in Madison County after seeing a dramatic increase in reported syphilis cases since last year.
NHS UK Announces a New Way to Quickly Diagnose Throat Infections
November 22nd 2016A new service in the United Kingdom, made possible by the National Health Service, reportedly offers a fast and accurate diagnosis of bacterial throat infections, promising a new way to reduce unnecessary antibiotic prescriptions.
Zika Virus is No Longer a Public Health Emergency of International Concern
November 21st 2016Although infection with the Zika virus remains a "public health challenge," as it is still circulating in many parts of the world, the World Health Organization no longer deems it one of international concern.
Herpesviruses Not as Host-specific as Once Thought
November 19th 2016Researchers from Lebniz Institute for Zoo and Wildlife Research in Berlin, Germany conducted a study to test the hypothesis of host-restricted virus coevolution within gammaherpesviruses. The researchers produced the largest dataset of gammaherpesvirus sequences to date.
Buyers Clubs Big Business for HIV and HCV Drugs
November 18th 2016Buyers clubs are still going strong in the United States and around the world as the offer a low-cost alternative for individuals with HIV and hepatitis c virus (HCV) who often find themselves struggling to pay for the expensive medications they need to treat their illness.